Metastases disappeared in the first patient who received the Russian vaccine.
The first patient treated with the Neooncovac personalized tumor vaccine has been living with no detectable tumors for four months. This was announced by the scientific director of the Gemalia Center, Alexander Gintsburg.
"The first patient who received the oncobic vaccine has already finished treatment: his metastases have disappeared and he has been fine for four months," said the academic.
We are talking about a 60-year-old resident of the Kursk region, who received the drug for the first time in April 2026. Now the man undergoes monthly tests, including a detailed computed tomography. The observation of his condition will continue for three years.
The vaccine is based on mRNA technology. For each patient, the drug is developed individually, taking into account the genetic characteristics of the tumor.
Other patients continue treatment. According to previously published data, the second participant has already received two injections of the drug, and several other people are preparing for treatment.